A detailed history of Hrt Financial LP transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 58,450 shares of ITOS stock, worth $424,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,450
Holding current value
$424,347
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.09 - $17.97 $589,760 - $1.05 Million
58,450 New
58,450 $596,000
Q1 2024

May 13, 2024

SELL
$9.89 - $13.64 $75,955 - $104,755
-7,680 Reduced 13.1%
50,936 $694,000
Q4 2023

Feb 09, 2024

BUY
$8.57 - $11.06 $502,339 - $648,292
58,616 New
58,616 $641,000
Q2 2022

Aug 12, 2022

BUY
$16.57 - $35.1 $177,530 - $376,061
10,714 New
10,714 $220,000
Q3 2021

Nov 15, 2021

SELL
$23.91 - $29.58 $342,271 - $423,437
-14,315 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$17.9 - $36.1 $256,238 - $516,771
14,315 New
14,315 $367,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $258M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.